Nemaura Medical Past Earnings Performance

Past criteria checks 0/6

Nemaura Medical's earnings have been declining at an average annual rate of -26.7%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 48.6% per year.

Key information

-26.7%

Earnings growth rate

-20.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate48.6%
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Nemaura Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:N18A Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-1182
30 Sep 230-1062
30 Jun 230-1362
31 Mar 230-1462
31 Dec 220-1342
30 Sep 221-1562
30 Jun 221-1462
31 Mar 221-1462
31 Dec 210-1251
30 Sep 210-1041
30 Jun 210-942
31 Mar 210-632
31 Dec 200-532
30 Sep 200-432
30 Jun 200-432
31 Mar 200-432
31 Dec 190-432
30 Sep 190-532
30 Jun 190-532
31 Mar 190-422
31 Dec 180-322
30 Sep 180-312
30 Jun 180-211
31 Mar 180-211
31 Dec 170-211
30 Sep 170-211
30 Jun 170-111
31 Mar 170-211
31 Dec 160-211
30 Sep 160-211
30 Jun 160-211
31 Mar 160-211
31 Dec 150-211
30 Sep 150-101
30 Jun 150-111
31 Mar 150-101
31 Dec 140-101
30 Sep 140-101
30 Jun 140-100
31 Mar 140-100

Quality Earnings: N18A is currently unprofitable.

Growing Profit Margin: N18A is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: N18A is unprofitable, and losses have increased over the past 5 years at a rate of 26.7% per year.

Accelerating Growth: Unable to compare N18A's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: N18A is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: N18A's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.